CathWorks reported the completion of a $30 million Series D financing round. Proceeds from the financing will be used to expand commercialization of the company's FFRangio system.
Who to call at CathWorks, and when
A new round usually means CathWorks is about to hire and buy. The teams that reach out first get the meeting.
An alert the day CathWorks raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at CathWorks, from your own LinkedIn network
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
CathWorks
Location
California, United States
About
CathWorks is a global leader in medical device digital health innovations, specifically focusing on transforming how cardiovascular disease is diagnosed and treated. Their flagship product, the FFRangio System, aims to enhance the diagnosis and management of coronary artery disease. By providing more accurate physiological assessments, CathWorks strives to redefine standards of care and improve patient outcomes in cardiology. The company is committed to advancing clinical evidence and addressing the gaps in adoption of innovative healthcare technologies.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment CathWorks raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
CaliforniaBiotechnologyHealth CareMedicalMedical DeviceHealth Diagnostics